brolucizumab

Spain

Drugs containing this active substance

  • BEOVU 120 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

    It is used in adults to treat eye conditions caused by the growth of abnormal blood vessels under the macula, such as exudative age-related macular degeneration (exudative AMD) and diabetic macular edema (DME).

    Form: solution for injection in a pre-filled syringe

    Active substance Dosage
    brolucizumab 19,8 mg

    ATC: S01L S01LA S01LA06

    Manufacturer: Novartis Europharm Limited